Literature DB >> 18759330

Early dopasensitive Parkinsonism related to myotonic dystrophy type 2.

Agnès Annic, David Devos, Alain Destée, Luc Defebvre, Arnaud Lacour, Jean-François Hurtevent, Tanya Stojkovic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18759330     DOI： 10.1002/mds.22239

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  7 in total

1.  Frontostriatal dysexecutive syndrome: a core cognitive feature of myotonic dystrophy type 2.

Authors:  Stojan Peric; Gorana Mandic-Stojmenovic; Elka Stefanova; Dusanka Savic-Pavicevic; Jovan Pesovic; Vera Ilic; Valerija Dobricic; Ivana Basta; Dragana Lavrnic; Vidosava Rakocevic-Stojanovic
Journal:  J Neurol       Date:  2014-10-28       Impact factor: 4.849

2.  Genetic players in multiple system atrophy: unfolding the nature of the beast.

Authors:  Sylvia Stemberger; Sonja W Scholz; Andrew B Singleton; Gregor K Wenning
Journal:  Neurobiol Aging       Date:  2011-05-24       Impact factor: 4.673

Review 3.  Multiple system atrophy: genetic or epigenetic?

Authors:  Edith Sturm; Nadia Stefanova
Journal:  Exp Neurobiol       Date:  2014-12-12       Impact factor: 3.261

Review 4.  Multiple system atrophy: the application of genetics in understanding etiology.

Authors:  Monica Federoff; Lucia V Schottlaender; Henry Houlden; Andrew Singleton
Journal:  Clin Auton Res       Date:  2015-02-17       Impact factor: 4.435

5.  Myotonic dystrophy-1 complicated by factor-v (leiden) mutation.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Case Rep Med       Date:  2015-03-30

6.  A Patient with Myotonic Dystrophy Type 1 Presenting as Parkinsonism.

Authors:  Ji-Hyun Choi; Jee-Young Lee; Han-Joon Kim; Beomseok Jeon
Journal:  J Mov Disord       Date:  2018-09-30

7.  Transcriptional signatures of synaptic vesicle genes define myotonic dystrophy type I neurodegeneration.

Authors:  Antonio Jimenez-Marin; Ibai Diez; Garazi Labayru; Andone Sistiaga; Maria C Caballero; Pol Andres-Benito; Jorge Sepulcre; Isidro Ferrer; Adolfo Lopez de Munain; Jesus M Cortes
Journal:  Neuropathol Appl Neurobiol       Date:  2021-05-17       Impact factor: 6.250
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.